Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rogler

Showing results (61-70 of 134) with videos related to

Pageof 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
Diffuse pseudoprogression in a patient with metastatic non-small-cell lung cancer treated with NivolumabA Curioni-Fontecedro, C Ickenberg, D Franzen, et al.
Der Internist|January 15, 2003
[Chronic inflammatory bowel diseases competence network. Results and significance for general practice]U R Fölsch, J Hoffmann, W Höhne, et al.
Gut|February 15, 2000
Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6R Daig, G Rogler, E Aschenbrenner, et al.
Clinical and Experimental Immunology|July 27, 2001
Subtractive screening reveals up-regulation of NADPH oxidase expression in Crohn's disease intestinal macrophagesM Hausmann, T Spöttl, T Andus, et al.
Zeitschrift Fur Gastroenterologie|July 11, 2006
Crohn's disease of the esophagus: treatment of an esophagobronchial fistula with the novel liquid embolic polymer "onyx"F Rieder, O Hamer, C Gelbmann, et al.
Gastroenterology|August 1, 1992
High-density lipoprotein 3 retroendocytosis: a new lipoprotein pathway in the enterocyte (Caco-2)G Rogler, G Herold, C Fahr, et al.
Laboratory Animals|July 6, 2013
Burrowing is a sensitive behavioural assay for monitoring general wellbeing during dextran sulfate sodium colitis in laboratory miceP Jirkof, K Leucht, N Cesarovic, et al.
Praxis|January 6, 2012
[Highlights in gastroenterology 2011]W Schwizer, G Rogler, T Rösch, et al.
Praxis|November 18, 2010
[Highlights in gastroenterology 2010]H-P Wirth, P Bauerfeind, M Häfner, et al.
Zeitschrift Fur Gastroenterologie|March 7, 2008
NAT1 genotypes do not predict response to mesalamine in patients with ulcerative colitisM Hausmann, G Paul, K Menzel, et al.
Pageof 14

Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
Diffuse pseudoprogression in a patient with metastatic non-small-cell lung cancer treated with NivolumabA Curioni-Fontecedro, C Ickenberg, D Franzen, et al.
Der Internist|January 15, 2003
[Chronic inflammatory bowel diseases competence network. Results and significance for general practice]U R Fölsch, J Hoffmann, W Höhne, et al.
Gut|February 15, 2000
Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6R Daig, G Rogler, E Aschenbrenner, et al.
Clinical and Experimental Immunology|July 27, 2001
Subtractive screening reveals up-regulation of NADPH oxidase expression in Crohn's disease intestinal macrophagesM Hausmann, T Spöttl, T Andus, et al.
Zeitschrift Fur Gastroenterologie|July 11, 2006
Crohn's disease of the esophagus: treatment of an esophagobronchial fistula with the novel liquid embolic polymer "onyx"F Rieder, O Hamer, C Gelbmann, et al.
Gastroenterology|August 1, 1992
High-density lipoprotein 3 retroendocytosis: a new lipoprotein pathway in the enterocyte (Caco-2)G Rogler, G Herold, C Fahr, et al.
Laboratory Animals|July 6, 2013
Burrowing is a sensitive behavioural assay for monitoring general wellbeing during dextran sulfate sodium colitis in laboratory miceP Jirkof, K Leucht, N Cesarovic, et al.
Praxis|January 6, 2012
[Highlights in gastroenterology 2011]W Schwizer, G Rogler, T Rösch, et al.
Praxis|November 18, 2010
[Highlights in gastroenterology 2010]H-P Wirth, P Bauerfeind, M Häfner, et al.
Zeitschrift Fur Gastroenterologie|March 7, 2008
NAT1 genotypes do not predict response to mesalamine in patients with ulcerative colitisM Hausmann, G Paul, K Menzel, et al.
Pageof 14